• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的钙卫蛋白:预测与投入

Calprotectin in Parkinsonian disease: Anticipation and dedication.

机构信息

Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.

Department of Nutrition, Faculty of Pharmacy and Medical Sciences, University of Petra, 11196 Amman, Jordan.

出版信息

Ageing Res Rev. 2024 Jan;93:102143. doi: 10.1016/j.arr.2023.102143. Epub 2023 Nov 25.

DOI:10.1016/j.arr.2023.102143
PMID:38008403
Abstract

Parkinson's disease (PD) is a neurodegenerative disease due to degeneration of dopaminergic neurons (DNs) in the substantia nigra pars compacta (SNpc). PD is characterized by motor and non-motor symptoms. Non-motor symptoms such as constipation and dysfunction of gastrointestinal tract (GIT) motility together with medications used in the management of PD affect gut microbiota. Alterations of gut microbiota with development of gut dyspiosis can induce momentous changes in gut barrier with subsequent systemic inflammation and induction of neuroinflammation. It has been shown that calprotectin which reflect intestinal inflammation and gut barrier injury are augmented in PD. Therefore, this review aims to elucidate the possible role of gut barrier injury and associated dysbiois in PD neuropathology, and how calprotectin reflects gut barrier injury in PD. Benefit of this review was to elucidate that high fecal calprotectin level in PD patients indicated gut dysbiosis and intestinal inflammation. Early increment of fecal calprotectin indicates the development of gut dysbiosis and/or gut-barrier injury which may precede motor symptoms by decades. Thus, fecal calprotectin could be a diagnostic and prognostic biomarker in PD. preclinical and clinical studies are warranted in this regard to emphasize the potential role of fecal calprotectin in PD neuropathology.

摘要

帕金森病(PD)是一种神经退行性疾病,由于黑质致密部(SNpc)中的多巴胺能神经元(DN)退化所致。PD 的特征是运动和非运动症状。非运动症状如便秘和胃肠道(GIT)运动功能障碍,以及用于管理 PD 的药物会影响肠道微生物群。肠道微生物群的改变和肠道失调的发展会导致肠道屏障发生重大变化,随后会发生全身炎症和神经炎症。已经表明,反映肠道炎症和肠道屏障损伤的钙卫蛋白在 PD 中增加。因此,本综述旨在阐明肠道屏障损伤和相关的肠道失调在 PD 神经病理学中的可能作用,以及钙卫蛋白如何反映 PD 中的肠道屏障损伤。本综述的意义在于阐明 PD 患者粪便钙卫蛋白水平升高表明肠道失调和肠道炎症。粪便钙卫蛋白的早期升高表明肠道失调和/或肠道屏障损伤的发展,这可能比运动症状早几十年。因此,粪便钙卫蛋白可能是 PD 的诊断和预后生物标志物。在这方面需要进行临床前和临床研究,以强调粪便钙卫蛋白在 PD 神经病理学中的潜在作用。

相似文献

1
Calprotectin in Parkinsonian disease: Anticipation and dedication.帕金森病中的钙卫蛋白:预测与投入
Ageing Res Rev. 2024 Jan;93:102143. doi: 10.1016/j.arr.2023.102143. Epub 2023 Nov 25.
2
Association of intestinal inflammation and permeability markers with clinical manifestations of Parkinson's disease.肠道炎症和通透性标志物与帕金森病临床表现的关联。
Parkinsonism Relat Disord. 2024 Jun;123:106948. doi: 10.1016/j.parkreldis.2024.106948. Epub 2024 Mar 27.
3
Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.粪便微生物群移植通过抑制脂多糖-TLR4 信号通路介导的炎症反应,经由肠道菌群-肠-脑轴保护鱼藤酮诱导的帕金森病小鼠。
Microbiome. 2021 Nov 17;9(1):226. doi: 10.1186/s40168-021-01107-9.
4
Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.肠道微生物群:帕金森病的新治疗靶点。
Front Immunol. 2022 Jun 24;13:937555. doi: 10.3389/fimmu.2022.937555. eCollection 2022.
5
Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.在帕金森病患者中,肠道炎症和肠道通透性的粪便标志物升高。
Parkinsonism Relat Disord. 2018 May;50:104-107. doi: 10.1016/j.parkreldis.2018.02.022. Epub 2018 Feb 12.
6
Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.帕金森病甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)小鼠模型的肠道病理学和肠道微生物组改变。
Neurochem Res. 2018 Oct;43(10):1986-1999. doi: 10.1007/s11064-018-2620-x. Epub 2018 Aug 31.
7
Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.帕金森病中肠道菌群改变和肠道通透性:管理的病理要点。
Neurosci Lett. 2019 Nov 1;712:134516. doi: 10.1016/j.neulet.2019.134516. Epub 2019 Sep 24.
8
Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.微生物群介导的帕金森病药物对雄性转基因小鼠帕金森病非运动症状的影响。
mSphere. 2024 Jan 30;9(1):e0037923. doi: 10.1128/msphere.00379-23. Epub 2023 Dec 11.
9
Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.帕金森病的胃肠功能障碍:肠道微生物组、益生菌和粪便微生物移植的分子病理学及其意义。
J Neurol. 2022 Mar;269(3):1154-1163. doi: 10.1007/s00415-021-10567-w. Epub 2021 Apr 21.
10
Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson's Disease.粪便钙卫蛋白作为肠道免疫系统激活的标志物在帕金森病中升高。
Front Neurosci. 2019 Sep 27;13:992. doi: 10.3389/fnins.2019.00992. eCollection 2019.

引用本文的文献

1
Targeting of the PI3 K/AKT/GSK3β Pathway in Parkinson's Disease: A Therapeutic Blueprint.帕金森病中PI3K/AKT/GSK3β信号通路的靶向治疗:一份治疗蓝图。
Mol Neurobiol. 2025 Jun 5. doi: 10.1007/s12035-025-05113-y.
2
Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.二甲双胍作为帕金森病辅助治疗的随机、双盲、安慰剂对照试验性研究。
Front Pharmacol. 2025 May 2;16:1497261. doi: 10.3389/fphar.2025.1497261. eCollection 2025.
3
Unlocking Alzheimer's Disease: The Role of BDNF Signaling in Neuropathology and Treatment.
揭开阿尔茨海默病之谜:脑源性神经营养因子信号传导在神经病理学及治疗中的作用
Neuromolecular Med. 2025 May 17;27(1):36. doi: 10.1007/s12017-025-08857-x.
4
Repurposing celecoxib as adjuvant therapy in patients with Parkinsonian disease: a new therapeutic dawn: randomized controlled pilot study.将塞来昔布重新用于帕金森病患者的辅助治疗:新的治疗曙光:随机对照初步研究。
Inflammopharmacology. 2024 Dec;32(6):3729-3738. doi: 10.1007/s10787-024-01567-z. Epub 2024 Sep 28.
5
Role of uric acid in neurodegenerative diseases, focusing on Alzheimer and Parkinson disease: A new perspective.尿酸在神经退行性疾病中的作用,重点关注阿尔茨海默病和帕金森病:一个新视角。
Neuropsychopharmacol Rep. 2024 Sep;44(3):639-649. doi: 10.1002/npr2.12445. Epub 2024 Jul 29.